دورية أكاديمية
Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?
| العنوان: | Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients? |
|---|---|
| المؤلفون: | Faizus Sazzad, Hai Dong Luo, Guohao Chang, Duoduo Wu, Zhi Xian Ong, Theo Kofidis, Giap Swee Kang |
| المصدر: | Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-9 (2024) |
| بيانات النشر: | BMC, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Surgery LCC:Anesthesiology |
| مصطلحات موضوعية: | Coronary artery bypass grafting, Intra-aortic balloon pump, Propensity score matching, In-hospital complications, Open heart surgery, Surgery, RD1-811, Anesthesiology, RD78.3-87.3 |
| الوصف: | Abstract Background The aim of this study was to determine whether pre-operative intra-aortic balloon pump (IABP) insertion improves surgical outcomes in high-risk coronary artery bypass grafting (CABG) patients. Methods Patients with a EuroSCORE II greater than 1.2% who underwent CABG from 2009 to 2016 were included in the study, while those who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing preoperative IABP insertion (EuroSCORE II > 5.018%) and 1198 patients in the non-IABP group before matching; after propensity score matching (PSM), both groups consisted of a matched cohort of 250 patients. Results 30-day mortality events occurred in 9 (3.6%) non-IABP group and in 12 (4.8%) IABP patients (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p = 0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value = 0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value = 0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value = 0.011). Conclusion Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1749-8090 |
| Relation: | https://doaj.org/toc/1749-8090 |
| DOI: | 10.1186/s13019-024-02925-2 |
| URL الوصول: | https://doaj.org/article/746287910c07411487d5ec66a4a9b33a |
| رقم الأكسشن: | edsdoj.746287910c07411487d5ec66a4a9b33a |
| قاعدة البيانات: | Directory of Open Access Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 17498090 |
|---|---|
| DOI: | 10.1186/s13019-024-02925-2 |